Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial?

[1]  J. Stoner,et al.  Prevalence of Vitamin D Insufficiency and Deficiency in Morbidly Obese Patients: A Comparison with Non-Obese Controls , 2008, Obesity surgery.

[2]  M. Holick Vitamin D deficiency. , 2007, The New England journal of medicine.

[3]  N. Nilubol,et al.  Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism. , 2007, Surgery.

[4]  J. Chandler,et al.  The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation , 2006, Journal of internal medicine.

[5]  A. Dackiw,et al.  25-hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy. , 2005, Surgery.

[6]  P. Vestergaard,et al.  Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism , 2005, Clinical endocrinology.

[7]  M. Holick,et al.  Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. , 2005, The Journal of clinical endocrinology and metabolism.

[8]  I. Reid,et al.  Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. , 2005, The Journal of clinical endocrinology and metabolism.

[9]  G. Åkerström,et al.  Vitamin D in normal and pathological parathyroid glands: new prospects for treating hyperparathyroidism (review). , 2005, International journal of molecular medicine.

[10]  O. Clark,et al.  Persistent and recurrent hyperparathyroidism , 2004, Current treatment options in oncology.

[11]  G. Irvin,et al.  Progress in the Operative Management of Sporadic Primary Hyperparathyroidism Over 34 Years , 2004, Annals of surgery.

[12]  Kirk A Easley,et al.  Double adenomas revisited: nonuniform distribution favors enlarged superior parathyroids (fourth pouch disease). , 2003, Surgery.

[13]  A. Mithal,et al.  Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective. , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  E. Mason,et al.  Severe Metabolic Bone Disease as a Long-Term Complication of Obesity Surgery , 2002, Obesity surgery.

[15]  P. Lindblom,et al.  Multifactorial risk profile for bone fractures in primary hyperparathyroidism , 2002, World Journal of Surgery.

[16]  J. Bilezikian Primary hyperparathyroidism. When to observe and when to operate. , 2000, Endocrinology and metabolism clinics of North America.

[17]  Md. Hasan Raza Ansari,et al.  Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. , 2000, The Journal of clinical endocrinology and metabolism.

[18]  D. Dempster,et al.  The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. , 1999, The American journal of medicine.

[19]  D. Feldman Vitamin D, parathyroid hormone, and calcium: a complex regulatory network. , 1999, The American journal of medicine.

[20]  R. Vieth,et al.  Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. , 1999, The American journal of clinical nutrition.

[21]  Barrett T. Kitch,et al.  Hypovitaminosis D in medical inpatients. , 1998, The New England journal of medicine.

[22]  P. Adams,et al.  The role of 1,25‐dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency , 1992, Clinical endocrinology.

[23]  M. Chapuy,et al.  CHAPTER 66 – Vitamin D Insufficiency in Adults and the Elderly , 1997 .

[24]  J. Berry,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Increased Catabolism of 25-Hydroxyvitamin D in Patients with Partial Gastrectomy and Elevated 1,25- Dihydroxyvitamin D Levels. Implications for Me , 2022 .